Post-endotoxin exposure-induced lung inflammation and resolution consequences beneficially impacted by lung-delivered IL-10 therapy

Abstract Although lung diseases typically result from long-term exposures, even a robust, one-time exposure can result in long-lasting consequences. Endotoxin is a ubiquitous environmental/occupational inflammatory agent often used to model airway inflammation. Using a murine model, the return to lu...

Full description

Bibliographic Details
Main Authors: Jill A. Poole, Rohit Gaurav, Aaron Schwab, Amy J. Nelson, Angela Gleason, Debra J. Romberger, Todd A. Wyatt
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-22346-2
_version_ 1798029950465343488
author Jill A. Poole
Rohit Gaurav
Aaron Schwab
Amy J. Nelson
Angela Gleason
Debra J. Romberger
Todd A. Wyatt
author_facet Jill A. Poole
Rohit Gaurav
Aaron Schwab
Amy J. Nelson
Angela Gleason
Debra J. Romberger
Todd A. Wyatt
author_sort Jill A. Poole
collection DOAJ
description Abstract Although lung diseases typically result from long-term exposures, even a robust, one-time exposure can result in long-lasting consequences. Endotoxin is a ubiquitous environmental/occupational inflammatory agent often used to model airway inflammation. Using a murine model, the return to lung homeostasis following high dose inhalant lipopolysaccharide (LPS, 10–100 μg) exposure were delineated over 2 weeks. LPS-induced rapid weight loss, release of proinflammatory mediators, and inflammatory cell influx with prolonged persistence of activated macrophages CD11c+CD11b+ and recruited/transitioning CD11cintCD11b+ monocyte-macrophages out to 2 weeks. Next, lung-delivered recombinant (r) interleukin (IL)-10 was intratracheally administered for 3 doses initiated 5 h following LPS (10 μg) exposure for 2 days. IL-10 therapy reduced LPS-induced weight loss and increased blood glucose levels. Whereas there was no difference in LPS-induced bronchoalveolar lavage airway fluid cellular influx, total lung cell infiltrates were reduced (37%) with rIL-10 treatment. Post-LPS exposure treatment with rIL-10 strikingly reduced lavage fluid and lung homogenate levels of tumor necrosis factor-α (88% and 93% reduction, respectively), IL-6 (98% and 94% reduction), CXCL1 (66% and 75% reduction), and CXCL2 (47% and 67% reduction). LPS-induced recruited monocyte-macrophages (CD11cintCD11b+) were reduced (68%) with rIL-10. Correspondingly, LPS-induced lung tissue CCR2+ inflammatory monocyte-macrophage were reduced with rIL-10. There were also reductions in LPS-induced lung neutrophils, lymphocyte subpopulations, collagen content, and vimentin expression. These findings support the importance of studying resolution processes for the development of treatment after unintended environmental/occupational biohazard exposures. Short-term, lung-delivered rIL-10 favorably hastened inflammatory recovery processes following acute, high dose inhalant LPS exposure.
first_indexed 2024-04-11T19:32:17Z
format Article
id doaj.art-d9e34725e3f947fca0ec69cbdd3492d4
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T19:32:17Z
publishDate 2022-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-d9e34725e3f947fca0ec69cbdd3492d42022-12-22T04:06:57ZengNature PortfolioScientific Reports2045-23222022-10-0112111410.1038/s41598-022-22346-2Post-endotoxin exposure-induced lung inflammation and resolution consequences beneficially impacted by lung-delivered IL-10 therapyJill A. Poole0Rohit Gaurav1Aaron Schwab2Amy J. Nelson3Angela Gleason4Debra J. Romberger5Todd A. Wyatt6Department of Internal Medicine, College of Medicine, University of Nebraska Medical CenterDepartment of Internal Medicine, College of Medicine, University of Nebraska Medical CenterDepartment of Internal Medicine, College of Medicine, University of Nebraska Medical CenterDepartment of Internal Medicine, College of Medicine, University of Nebraska Medical CenterDepartment of Internal Medicine, College of Medicine, University of Nebraska Medical CenterDepartment of Internal Medicine, College of Medicine, University of Nebraska Medical CenterDepartment of Internal Medicine, College of Medicine, University of Nebraska Medical CenterAbstract Although lung diseases typically result from long-term exposures, even a robust, one-time exposure can result in long-lasting consequences. Endotoxin is a ubiquitous environmental/occupational inflammatory agent often used to model airway inflammation. Using a murine model, the return to lung homeostasis following high dose inhalant lipopolysaccharide (LPS, 10–100 μg) exposure were delineated over 2 weeks. LPS-induced rapid weight loss, release of proinflammatory mediators, and inflammatory cell influx with prolonged persistence of activated macrophages CD11c+CD11b+ and recruited/transitioning CD11cintCD11b+ monocyte-macrophages out to 2 weeks. Next, lung-delivered recombinant (r) interleukin (IL)-10 was intratracheally administered for 3 doses initiated 5 h following LPS (10 μg) exposure for 2 days. IL-10 therapy reduced LPS-induced weight loss and increased blood glucose levels. Whereas there was no difference in LPS-induced bronchoalveolar lavage airway fluid cellular influx, total lung cell infiltrates were reduced (37%) with rIL-10 treatment. Post-LPS exposure treatment with rIL-10 strikingly reduced lavage fluid and lung homogenate levels of tumor necrosis factor-α (88% and 93% reduction, respectively), IL-6 (98% and 94% reduction), CXCL1 (66% and 75% reduction), and CXCL2 (47% and 67% reduction). LPS-induced recruited monocyte-macrophages (CD11cintCD11b+) were reduced (68%) with rIL-10. Correspondingly, LPS-induced lung tissue CCR2+ inflammatory monocyte-macrophage were reduced with rIL-10. There were also reductions in LPS-induced lung neutrophils, lymphocyte subpopulations, collagen content, and vimentin expression. These findings support the importance of studying resolution processes for the development of treatment after unintended environmental/occupational biohazard exposures. Short-term, lung-delivered rIL-10 favorably hastened inflammatory recovery processes following acute, high dose inhalant LPS exposure.https://doi.org/10.1038/s41598-022-22346-2
spellingShingle Jill A. Poole
Rohit Gaurav
Aaron Schwab
Amy J. Nelson
Angela Gleason
Debra J. Romberger
Todd A. Wyatt
Post-endotoxin exposure-induced lung inflammation and resolution consequences beneficially impacted by lung-delivered IL-10 therapy
Scientific Reports
title Post-endotoxin exposure-induced lung inflammation and resolution consequences beneficially impacted by lung-delivered IL-10 therapy
title_full Post-endotoxin exposure-induced lung inflammation and resolution consequences beneficially impacted by lung-delivered IL-10 therapy
title_fullStr Post-endotoxin exposure-induced lung inflammation and resolution consequences beneficially impacted by lung-delivered IL-10 therapy
title_full_unstemmed Post-endotoxin exposure-induced lung inflammation and resolution consequences beneficially impacted by lung-delivered IL-10 therapy
title_short Post-endotoxin exposure-induced lung inflammation and resolution consequences beneficially impacted by lung-delivered IL-10 therapy
title_sort post endotoxin exposure induced lung inflammation and resolution consequences beneficially impacted by lung delivered il 10 therapy
url https://doi.org/10.1038/s41598-022-22346-2
work_keys_str_mv AT jillapoole postendotoxinexposureinducedlunginflammationandresolutionconsequencesbeneficiallyimpactedbylungdeliveredil10therapy
AT rohitgaurav postendotoxinexposureinducedlunginflammationandresolutionconsequencesbeneficiallyimpactedbylungdeliveredil10therapy
AT aaronschwab postendotoxinexposureinducedlunginflammationandresolutionconsequencesbeneficiallyimpactedbylungdeliveredil10therapy
AT amyjnelson postendotoxinexposureinducedlunginflammationandresolutionconsequencesbeneficiallyimpactedbylungdeliveredil10therapy
AT angelagleason postendotoxinexposureinducedlunginflammationandresolutionconsequencesbeneficiallyimpactedbylungdeliveredil10therapy
AT debrajromberger postendotoxinexposureinducedlunginflammationandresolutionconsequencesbeneficiallyimpactedbylungdeliveredil10therapy
AT toddawyatt postendotoxinexposureinducedlunginflammationandresolutionconsequencesbeneficiallyimpactedbylungdeliveredil10therapy